Poland – Pharmaceutical products – Supply of program drugs and contrast agents

Opportunity description

The subject matter of the procedure is the supply of program drugs and contrast agents. The subject matter of the contract is the supply of Rucaparib. The subject matter of the contract is the supply of Lazertinib. The subject matter of the contract is the supply of Omaveloxolone. The subject matter of the contract is the supply of Vorasidenib. The subject matter of the contract is the supply of Dostarlimab The subject matter of the contract is the supply of Tezepelumab The subject matter of the contract is the supply of Ifosfamide The subject matter of the contract is the supply of Immunoglobulin The subject matter of the contract is the supply of Somatropin The subject matter of the contract is the supply of a NON-IONIC DIMERIC CONTRAST AGENT The subject matter of the contract is the supply of Contrast Agents FOR USE IN CT AND MRI The subject matter of the contract is the supply of ionic and non-ionic Contrast Agents The subject matter of the contract is the supply of BARIUM SULFATE The subject matter of the contract is the supply of a non-ionic, triiodinated contrast agent for angiography The subject matter of the contract is the supply of a contrast agent for MRI The subject matter of the contract is the supply of a Paramagnetic contrast agent The subject matter of the contract is the supply of Drugs Reversing THE EFFECTS OF ANTICOAGULANT DRUGS The subject matter of the contract is the supply of a drug FOR THE ALS TREATMENT DRUG PROGRAM The subject matter of the contract is the supply of HUMAN RECOMBINANT IG WITH HYALURONIDASE FOR SUBCUTANEOUS ADMINISTRATION The subject matter of the contract is the supply of a drug for drug program B.133 The subject matter of the contract is the supply of a paramagnetic, gadolinium-based, hepatotropic contrast agent for MRI The subject matter of the contract is the supply of CONTRAST AGENTS FOR ULTRASOUND EXAMINATIONS Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.